Gene · 7941
Papers4,339
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,339
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LDL binding to cell receptors and extracellular matrix is proatherogenic in obesity but improves after bariatric surgery. | J Lipid Res | 2023 | 37777014 | PubTator, text mining | PubMed |
| Risk Factors for Post-Stroke Pneumonia in a Patient Population with Subacute Stroke: A Retrospective Cohort Study. | J Clin Med | 2023 | 37762776 | PubTator, text mining | PubMed |
| Novel Therapeutic Approaches to Prevent Atherothrombotic Ischemic Stroke in Patients with Carotid Atherosclerosis. | Int J Mol Sci | 2023 | 37762627 | PubTator, text mining | PubMed |
| Lipoprotein-Associated Phospholipase A2 has Comparable Ability as Anthropometric Indices to Discriminate Cardiovascular Disease Risk: A Cross-Sectional Study. | West Afr J Med | 2023 | 37761388 | PubTator, text mining | PubMed |
| Modulation of the Cellular microRNA Landscape: Contribution to the Protective Effects of High-Density Lipoproteins (HDL). | Biology (Basel) | 2023 | 37759631 | PubTator, text mining | PubMed |
| High-Throughput Screening of the Repurposing Hub Library to Identify Drugs with Novel Inhibitory Activity against Candida albicans and Candida auris Biofilms. | J Fungi (Basel) | 2023 | 37754987 | PubTator, text mining | PubMed |
| Lipoprotein(a) as a Risk Factor for Cardiovascular Diseases: Pathophysiology and Treatment Perspectives. | Int J Environ Res Public Health | 2023 | 37754581 | PubTator, text mining | PubMed |
| News & views: anti-amyloid antibodies and novel emerging approaches to Alzheimer's disease in 2023. | Mol Neurodegener | 2023 | 37749530 | PubTator, text mining | PubMed |
| Whole Genome Sequencing Based Analysis of Inflammation Biomarkers in the Trans-Omics for Precision Medicine (TOPMed) Consortium. | bioRxiv | 2023 | 37745480 | PubTator, text mining | PubMed |
| Biomarkers associated with functional improvement after stroke rehabilitation: a systematic review and meta-analysis of randomized controlled trials. | Front Neurol | 2023 | 37731856 | PubTator, text mining | PubMed |
| The lipoprotein-associated phospholipase A2 inhibitor Darapladib sensitises cancer cells to ferroptosis by remodelling lipid metabolism. | Nat Commun | 2023 | 37714840 | PubTator, text mining | PubMed |
| Investigating the potential mechanism of quercetin against cervical cancer. | Discov Oncol | 2023 | 37704909 | PubTator, text mining | PubMed |
The association between dietary quality scores with C-reactive protein and novel biomarkers of inflammation platelet-activating factor and lipoprotein-associated phospholipase A2: a cross-sectional study. | Nutr Metab (Lond) | 2023 | 37700354 | PubTator, text mining | PubMed |
| Identification of metabolic biomarkers associated with nonalcoholic fatty liver disease. | Lipids Health Dis | 2023 | 37697333 | PubTator, text mining | PubMed |
| Recent Advances in Nanozyme-Mediated Strategies for Pathogen Detection and Control. | Int J Mol Sci | 2023 | 37686145 | PubTator, text mining | PubMed |
| A Scoping Review on Biomarkers of Endothelial Dysfunction in Small Vessel Disease: Molecular Insights from Human Studies. | Int J Mol Sci | 2023 | 37685924 | PubTator, text mining | PubMed |
| Demonstration of the impact of COVID-19 on metabolic associated fatty liver disease by bioinformatics and system biology approach. | Medicine (Baltimore) | 2023 | 37657050 | PubTator, text mining | PubMed |
| Nutritional Risk and Sarcopenia Features in Patients with Crohn's Disease: Relation to Body Composition, Physical Performance, Nutritional Questionnaires and Biomarkers. | Nutrients | 2023 | 37630805 | PubTator, text mining | PubMed |
| Hypertrophic Cardiomyopathy: Genetic Foundations, Outcomes, Interconnections, and Their Modifiers. | Medicina (Kaunas) | 2023 | 37629714 | PubTator, text mining | PubMed |
| Novel Anti-Inflammatory Therapies in Coronary Artery Disease and Acute Coronary Syndromes. | Life (Basel) | 2023 | 37629526 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7941/papers?page=18